Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study.

Gobbi G, Comai S, Debonnel G.

Neuropsychiatr Dis Treat. 2014 May 7;10:757-65. doi: 10.2147/NDT.S59968. eCollection 2014.

2.

Quetiapine : A Review of its Use in Schizophrenia.

Gunasekara NS, Spencer CM.

CNS Drugs. 1998 Apr;9(4):325-40. doi: 10.2165/00023210-199809040-00007.

PMID:
27521016
3.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

4.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.
7.

An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder.

Peuskens J, Devoitille JM, Kusters J, Vandenhoven G.

Int J Psychiatry Clin Pract. 2008;12(4):261-7. doi: 10.1080/13651500802085369.

PMID:
24937712
8.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
9.

A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.

Sacchetti E, Valsecchi P, Parrinello G; QUERISOLA Group..

Schizophr Res. 2008 Jan;98(1-3):55-65. Epub 2007 Oct 15.

PMID:
17933497
10.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group..

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
11.

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.

Riedel M, Müller N, Spellmann I, Engel RR, Musil R, Valdevit R, Dehning S, Douhet A, Cerovecki A, Strassnig M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):402-12.

PMID:
17629725
12.

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA.

Am J Psychiatry. 2007 Jul;164(7):1061-71.

13.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
14.

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study.

Gabriel A.

Neuropsychiatr Dis Treat. 2013;9:485-92. doi: 10.2147/NDT.S42745. Epub 2013 Apr 12.

15.

Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.

Nakajima S, Takeuchi H, Fervaha G, Plitman E, Chung JK, Caravaggio F, Iwata Y, Mihashi Y, Gerretsen P, Remington G, Mulsant B, Graff-Guerrero A.

Schizophr Res. 2015 Feb;161(2-3):429-33. doi: 10.1016/j.schres.2014.12.024. Epub 2014 Dec 30.

16.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
18.

Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.

Villari V, Rocca P, Fonzo V, Montemagni C, Pandullo P, Bogetto F.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):405-13. Epub 2007 Sep 15.

PMID:
17900775
19.

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H.

Psychopharmacology (Berl). 2007 Dec;195(2):285-95. Epub 2007 Aug 14.

PMID:
17701027
20.

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

De Nayer A, Windhager E, Irmansyah, Larmo I, Lindenbauer B, Rittmannsberger H, Platz T, Jones A, Whiteford J, Altman C.

Int J Psychiatry Clin Pract. 2003;7(1):59-66. doi: 10.1080/13651500310001095.

PMID:
24937244

Supplemental Content

Support Center